Results from different patient populations using combined therapy with alprostadil and sildenafil: predictors of satisfaction-Reference-Cited by-同舟云学术

Results from different patient populations using combined therapy with alprostadil and sildenafil: predictors of satisfaction

Published:2000-09 Issue:4 Volume:86 Page:469-473
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Mydlo J.H.,Volpe M.A.,Macchia R.J.

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1464-410X.2000.00790.x/fullpdf

Reference19 articles.

1. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence

2. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study;Feldman;J Urol,1994

3. A brief male sexual function inventory for urology;O'leary;Urology,1993

4. Clinical guidelines panel on erectile dysfunction: summary report on the treatment of organic erectile dysfunction;Montague;J Urol,1996

5. Erection disorders: efficacy and tolerability after 6 months of intracavernous self injections of alprostadil. Group Francais d'etude de l'alprostadil;Guiliano;Presse Med,1994

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Erectile response profiles of men using PDE5 inhibitors combined with intracavernosal injections as part of a penile rehabilitation program after radical prostatectomy;The Journal of Sexual Medicine;2023-11-16

2. Inflatable Penile Prosthesis in the Ambulatory Surgical Setting: Outcomes From a Large Urological Group Practice;The Journal of Sexual Medicine;2020-05

3. Inflatable Penile Prosthesis Implantation in the Ambulatory Setting: A Systematic Review;Sexual Medicine Reviews;2020-04

4. Additional non-invasive options can be considered for erectile dysfunction when phosphodiesterase type 5 inhibitors fail;Drugs & Therapy Perspectives;2018-09-06

5. Non-invasive Management Options for Erectile Dysfunction When a Phosphodiesterase Type 5 Inhibitor Fails;Drugs & Aging;2018-02-20